SCHEMBL19726720

SCHEMBL19726720

COC(=O)c1cccc(C(=O)Cl)c1C

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.50
TSHR P16473 1/20 0.50
ALDH1A1 P00352 4/20 0.48
CFTR P13569 1/20 0.48
HSD17B10 Q99714 1/20 0.48
FFAR4 Q5NUL3 1/20 0.48
KDM4E B2RXH2 3/20 0.47
POLB P06746 2/20 0.47
ATM Q13315 1/20 0.47
MYC P01106 1/20 0.46
SLC6A4 P31645 1/20 0.45
SLC6A3 Q01959 1/20 0.45
RAB9A P51151 1/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
CA12 O43570 1/20 0.44
CA7 P43166 1/20 0.44
CA14 Q9ULX7 1/20 0.44
CA5A P35218 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3511612 0.90 LMNA (0.59) LMNATSHRALDH1A1CFTRHSD17B10
SCHEMBL2300929 0.85 ALDH1A1 (0.50) LMNATSHRALDH1A1HSD17B10KDM4E
SCHEMBL16953017 0.82 LMNA (0.52) LMNATSHRALDH1A1CFTRHSD17B10
SCHEMBL164597 0.82 TSHR (0.53) LMNATSHRALDH1A1CFTRHSD17B10
SCHEMBL305237 0.82 TSHR (0.61) LMNATSHRALDH1A1CFTRHSD17B10
SCHEMBL23909537 0.81 LMNA (0.50) LMNATSHRALDH1A1CFTRHSD17B10
SCHEMBL29934048 0.81 ALDH1A1 (0.53) LMNATSHRALDH1A1CFTRHSD17B10
SCHEMBL724484 0.81 NR4A2 (0.53) LMNATSHRALDH1A1CFTRHSD17B10
SCHEMBL28703029 0.81 LMNA (0.50) LMNATSHRALDH1A1CFTRHSD17B10
SCHEMBL9259479 0.81 ALDH1A1 (0.53) LMNATSHRALDH1A1CFTRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170360956-A1 FUNCTIONALIZED LINEAR LIGANDS AND COMPLEXES THEREOF LUMIPHORE, INC. 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170360956-A1 FUNCTIONALIZED LINEAR LIGANDS AND COMPLEXES THEREOF CLTB, CLTA, EPCAM LMNA 1626/4885TSHR 804/4885ALDH1A1 1477/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.